An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis

This publication has 31 references indexed in Scilit:

• A new look at tumour immunology
  European Journal Of Cancer, 1992
• Memory of butyrate induction by the moloney murine sarcoma virus enhancer-promoter element
  Biochemical and Biophysical Research Communications, 1992
• Fibrosis in immune control of mammary-tumor growth
  International Journal of Cancer, 1992
• Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines
  Cancer Immunology, Immunotherapy, 1992
• Human melanoma cells with high susceptibility to cell‐mediated lysis can be identified on the basis of icam‐1 phenotype, vla profile and invasive ability
  International Journal of Cancer, 1990
• Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: an association of high acetate and low butyrate ratios with adenomatous polyps and colon cancer.
  Gut, 1988
• SEROLOGICAL EVIDENCE FOR A DEFECT IN RT1.B (I-A) EXPRESSION BY THE BDIX RAT STRAIN
  European Journal of Immunogenetics, 1987
• An immunohistological study of cells infiltrating progressive and regressive tumors induced by two variant subpopulations of a rat colon cancer cell line
  International Journal of Cancer, 1987
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Butyrate-synchronized cloned T cells retain their dependence on interleukin-2 for growth induction
  Experimental Cell Research, 1987